{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:58:51Z","timestamp":1781060331283,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mugla Sitki KocmanUniversity"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Home-based chemotherapy via port catheters offers logistical and potential psychological benefits but may pose unique challenges for patients undergoing prolonged regimens such as mFOLFOX6. Evidence on the association between home-based infusion and anxiety, quality of life, and healthcare use in gastrointestinal (GI) cancer patients remains limited. In this prospective study, 190 GI cancer patients scheduled for adjuvant mFOLFOX6 were enrolled between July 2020 and December 2024. Patients chose either home-based port infusion (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200994) or hospital-based peripheral infusion (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200996). Anxiety was assessed using the State-Trait Anxiety Inventory (STAI-1 and STAI-2), and quality of life via EORTC QLQ-C30 at baseline, after six cycles (~3\u00a0months), and after 12 cycles (~6\u00a0months). Treatment-related toxicities and emergency visits were recorded. Logistic regression identified factors associated with high anxiety, low quality of life, and emergency visits. Baseline characteristics were similar between groups except for younger age in the home-based group, which lost significance after Bonferroni correction. After six cycles, home-based patients showed significantly higher state and trait anxiety than hospital-based patients (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), though differences diminished by 12 cycles. Home-based patients also reported worse dyspnea, pain, fatigue, and nausea\/vomiting after six cycles, with most symptoms improving later. Emergency visits without organic pathology were more frequent in the home-based group (32% vs. 13%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.002), although this difference did not remain statistically significant after Bonferroni correction. Multivariable analysis identified home-based infusion, living alone, social inactivity, shorter treatment duration, and low quality of life as independent factors associated with high state anxiety. Similar factors were associated with high trait anxiety, low quality of life, and emergency visits. Home-based port infusion for mFOLFOX6 is associated with transient increases in anxiety and impairments in quality of life early in treatment, which diminished by the end of treatment. Psychosocial support and close follow-up may help reduce anxiety and unnecessary emergency visits, particularly for socially isolated patients. Further randomized studies are warranted.\n                  <\/jats:p>","DOI":"10.1007\/s00520-026-10790-z","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:25:50Z","timestamp":1779463550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of home-based port infusion versus hospital-based peripheral infusion on anxiety, quality of life, and emergency visits in gastrointestinal cancer: a prospective observational study by the Turkish Oncology Group (TOG)"],"prefix":"10.1007","volume":"34","author":[{"given":"Ozan Ahmet","family":"Cetin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turan","family":"Karaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Yavuzsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0598-7284","authenticated-orcid":false,"given":"Ozgur","family":"Tanriverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"3","key":"10790_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/cam4.3690","volume":"10","author":"N Kulthanachairojana","year":"2021","unstructured":"Kulthanachairojana N, Chansriwong P, Thokanit NS, Sirilerttrakul S, Wannakansophon N, Taychakhoonavudh S (2021) Home-based chemotherapy for stage III colon cancer patients in Thailand: cost-utility and budget impact analyses. Cancer Med 10(3):1027\u20131033. https:\/\/doi.org\/10.1002\/cam4.3690","journal-title":"Cancer Med"},{"key":"10790_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1335344","volume":"14","author":"E Villegas","year":"2024","unstructured":"Villegas E, Arru\u00f1ada M, Casado M\u00c1, Gonz\u00e1lez S, Moreno-Mart\u00ednez ME et al (2024) National expert consensus on home-administered oncologic therapies in Spain. Front Oncol 14:1335344. https:\/\/doi.org\/10.3389\/fonc.2024.1335344","journal-title":"Front Oncol"},{"issue":"2","key":"10790_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3892\/ol.2011.496","volume":"3","author":"HS Kim","year":"2012","unstructured":"Kim HS, Kim JH, Kim HJ, Jang HJ, Kim JB et al (2012) Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status. Oncol Lett 3(2):425\u2013428. https:\/\/doi.org\/10.3892\/ol.2011.496","journal-title":"Oncol Lett"},{"issue":"7","key":"10790_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/annonc\/mdw176","volume":"27","author":"G Folprecht","year":"2016","unstructured":"Folprecht G, Pericay C, Saunders MP, Thomas A, Lopez Lopez R et al (2016) Oxaliplatin and 5-FU\/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study. Ann Oncol 27(7):1273\u20131279. https:\/\/doi.org\/10.1093\/annonc\/mdw176","journal-title":"Ann Oncol"},{"issue":"1","key":"10790_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clcc.2014.11.002","volume":"14","author":"B Gustavsson","year":"2015","unstructured":"Gustavsson B, Carlsson G, Machover D, Petrelli N, Roth A et al (2015) A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorectal Cancer 14(1):1\u201310. https:\/\/doi.org\/10.1016\/j.clcc.2014.11.002","journal-title":"Clin Colorectal Cancer"},{"key":"10790_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"S Vodenkova","year":"2020","unstructured":"Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V (2020) 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther 206:107447. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107447","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10790_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.21873\/anticanres.15472","volume":"42","author":"S Quesada","year":"2022","unstructured":"Quesada S, Samalin E, Thezenas S, Khellaf L, Mourregot A et al (2022) Perioperative FOLFOX in patients with locally advanced oesogastric adenocarcinoma. Anticancer Res 42(1):185\u2013193. https:\/\/doi.org\/10.21873\/anticanres.15472","journal-title":"Anticancer Res"},{"issue":"2","key":"10790_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.14216\/kjco.21016","volume":"17","author":"J Lee","year":"2021","unstructured":"Lee J, Hur SM, Kim Z, Lim CW (2021) Safety of immediate use of totally implantable venous access ports in adult patients with cancer: a retrospective single-center study. Korean J Clin Oncol 17(2):104\u2013110. https:\/\/doi.org\/10.14216\/kjco.21016","journal-title":"Korean J Clin Oncol"},{"issue":"5","key":"10790_CR9","volume":"65","author":"FO Larsen","year":"2018","unstructured":"Larsen FO, Christiansen AB, Rish\u00f8j A, Nelausen KM, Nielsen DL (2018) Safety and feasibility of home-based chemotherapy. Dan Med J 65(5):A5482","journal-title":"Dan Med J"},{"issue":"7","key":"10790_CR10","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s11136-023-03365-6","volume":"32","author":"MA Eri\u015fen","year":"2023","unstructured":"Eri\u015fen MA, Y\u0131lmaz F\u00d6 (2023) Comparison of chemotherapy treatment administration via venous port and peripheral vascular access in terms of quality of life and costs. Qual Life Res 32(7):1897\u20131908. https:\/\/doi.org\/10.1007\/s11136-023-03365-6","journal-title":"Qual Life Res"},{"key":"10790_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104277","volume":"196","author":"C Duggan","year":"2024","unstructured":"Duggan C, Hernon O, Dunne R, McInerney V, Walsh SR et al (2024) Vascular access device type for systemic anti-cancer therapies in cancer patients: a scoping review. Crit Rev Oncol Hematol 196:104277. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104277","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1-2","key":"10790_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.hjdsi.2016.04.004","volume":"5","author":"JM Polinski","year":"2017","unstructured":"Polinski JM, Kowal MK, Gagnon M, Brennan TA, Shrank WH (2017) Home infusion: safe, clinically effective, patient preferred, and cost saving. Healthcare Basel 5(1\u20132):68\u201380. https:\/\/doi.org\/10.1016\/j.hjdsi.2016.04.004","journal-title":"Healthcare Basel"},{"issue":"2","key":"10790_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijnurstu.2003.05.002","volume":"41","author":"D Kelly","year":"2004","unstructured":"Kelly D, Pearce S, Butters E, Stevens W, Layzell S (2004) Achieving change in the NHS: a study to explore the feasibility of a home-based cancer chemotherapy service. Int J Nurs Stud 41(2):215\u2013224. https:\/\/doi.org\/10.1016\/j.ijnurstu.2003.05.002","journal-title":"Int J Nurs Stud"},{"issue":"1","key":"10790_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-024-02659-1","volume":"13","author":"P Witwaranukool","year":"2024","unstructured":"Witwaranukool P, Phonyiam R, Wu Y, Kynoch K (2024) Experiences and perceptions of patients with cancer receiving home-based chemotherapy: a qualitative systematic review protocol. Syst Rev 13(1):242. https:\/\/doi.org\/10.1186\/s13643-024-02659-1","journal-title":"Syst Rev"},{"issue":"1","key":"10790_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11937-z","volume":"24","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Zhao M, Tang W, Zheng X (2024) Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis. BMC Cancer 24(1):188. https:\/\/doi.org\/10.1186\/s12885-024-11937-z","journal-title":"BMC Cancer"},{"issue":"6","key":"10790_CR16","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1002\/nop2.1016","volume":"8","author":"S Sirilerttrakul","year":"2021","unstructured":"Sirilerttrakul S, Wannakansophon N, Utthiya P, Ckumdee S, Tangteerakoon P, Chansriwong P (2021) Evaluation of adverse events and health-related quality of life in patients with colorectal cancer receiving ambulatory home-based chemotherapy in Thailand. Nurs Open 8(6):3036\u20133044. https:\/\/doi.org\/10.1002\/nop2.1016","journal-title":"Nurs Open"},{"issue":"1","key":"10790_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04128-5","volume":"23","author":"L Shi","year":"2025","unstructured":"Shi L, Zhang J, Deng Y (2025) Associations of pretreatment emotional distress with adherence to therapy for patients with locally advanced rectal cancer: a post hoc analysis of the Chinese FOWARC phase 3 randomized clinical trial. BMC Med 23(1):293. https:\/\/doi.org\/10.1186\/s12916-025-04128-5","journal-title":"BMC Med"},{"issue":"1","key":"10790_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-024-02227-0","volume":"22","author":"J Dixit","year":"2024","unstructured":"Dixit J, Gupta N, Kataki A, Roy P, Mehra N et al (2024) Health-related quality of life and its determinants among cancer patients: evidence from 12,148 patients of Indian database. Health Qual Life Outcomes 22(1):26. https:\/\/doi.org\/10.1186\/s12955-024-02227-0","journal-title":"Health Qual Life Outcomes"},{"issue":"16","key":"10790_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16162827","volume":"16","author":"W Shalata","year":"2024","unstructured":"Shalata W, Gothelf I, Bernstine T, Michlin R, Tourkey L et al (2024) Mental health challenges in cancer patients: a cross-sectional analysis of depression and anxiety. Cancers (Basel) 16(16):2827. https:\/\/doi.org\/10.3390\/cancers16162827","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10790_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1158\/2767-9764.CRC-24-0631","volume":"5","author":"S Karovic","year":"2025","unstructured":"Karovic S, Dvergsten E, Pierattini C, Barac A, Fay L et al (2025) Real-world data on risk factors for emergency department visits to treat outpatient chemotherapy-associated toxicities. Cancer Res Commun 5(6):973\u2013980. https:\/\/doi.org\/10.1158\/2767-9764.CRC-24-0631","journal-title":"Cancer Res Commun"},{"key":"10790_CR21","volume-title":"Manual for the State-Trait Anxiety Inventory","author":"CD Spielberger","year":"1983","unstructured":"Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA"},{"key":"10790_CR22","volume-title":"Durumluk-Surekli kayg\u0131 envanteri el kitab\u0131","author":"N Oner","year":"1985","unstructured":"Oner N, Le Compte A (1985) Durumluk-Surekli kayg\u0131 envanteri el kitab\u0131. Bo\u011fazi\u00e7i Yay\u0131nlar\u0131, Istanbul"},{"issue":"5","key":"10790_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmadzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10790_CR24","first-page":"1283","volume":"12","author":"S Demirci","year":"2011","unstructured":"Demirci S, Eser E, Ozsaran Z, Tankisi D, Aras AB et al (2011) Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. Asian Pac J Cancer Prev 12(5):1283\u20131287","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"10790_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3390\/curroncol31020066","volume":"31","author":"A Kok","year":"2024","unstructured":"Kok A, Passchier E, May AM, Jager-Wittenaar H, Veenhof C et al (2024) Expectations and experiences of participating in a supervised and home-based physical exercise intervention in patients with head and neck cancer during chemoradiotherapy: a qualitative study. Curr Oncol 31(2):885\u2013899","journal-title":"Curr Oncol"},{"key":"10790_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00208","volume":"10","author":"A Seiler","year":"2019","unstructured":"Seiler A, Jenewein J (2019) Resilience in cancer patients. Front Psychiatry 10:208. https:\/\/doi.org\/10.3389\/fpsyt.2019.00208","journal-title":"Front Psychiatry"},{"key":"10790_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neubiorev.2020.06.030","volume":"116","author":"KGO Ike","year":"2020","unstructured":"Ike KGO, de Boer SF, Buwalda B, Kas MJH (2020) Social withdrawal: an initially adaptive behavior that becomes maladaptive when expressed excessively. Neurosci Biobehav Rev 116:251\u2013267. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.06.030","journal-title":"Neurosci Biobehav Rev"},{"key":"10790_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2024.102944","volume":"99","author":"S Ferro","year":"2025","unstructured":"Ferro S, Serra C (2025) Triage at shift changes and distortions in the perception and treatment of emergency patients. J Health Econ 99:102944. https:\/\/doi.org\/10.1016\/j.jhealeco.2024.102944","journal-title":"J Health Econ"},{"issue":"3","key":"10790_CR29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/jan.15055","volume":"78","author":"C Areia","year":"2022","unstructured":"Areia C, King E, Ede J, Young L, Tarassenko L, Watkinson P, Vollam S (2022) Experiences of current vital signs monitoring practices and views of wearable monitoring: a qualitative study in patients and nurses. J Adv Nurs 78(3):810\u2013822. https:\/\/doi.org\/10.1111\/jan.15055","journal-title":"J Adv Nurs"},{"key":"10790_CR30","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.2147\/PPA.S432821","volume":"17","author":"HY Yeo","year":"2023","unstructured":"Yeo HY, Liew AC, Chan SJ, Anwar M, Han CH, Marra CA (2023) Understanding patient preferences regarding the important determinants of breast cancer treatment: a narrative scoping review. Patient Prefer Adherence 17:2679\u20132706. https:\/\/doi.org\/10.2147\/PPA.S432821","journal-title":"Patient Prefer Adherence"},{"issue":"7","key":"10790_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103496","volume":"9","author":"F Stiefel","year":"2024","unstructured":"Stiefel F, Bourquin C, Salmon P, Achtari Jeanneret L, Dauchy S, ESMO Guidelines Committee et al (2024) Communication and support of patients and caregivers in chronic cancer care: ESMO Clinical Practice Guideline. ESMO Open 9(7):103496. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103496","journal-title":"ESMO Open"},{"issue":"2","key":"10790_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40487-018-0065-7","volume":"6","author":"TQ Wang","year":"2018","unstructured":"Wang TQ, Samuel JN, Brown MC, Vennettilli A, Solomon H et al (2018) Routine surveillance of chemotherapy toxicities in cancer patients using the patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Oncol Ther 6(2):189\u2013201. https:\/\/doi.org\/10.1007\/s40487-018-0065-7","journal-title":"Oncol Ther"},{"issue":"11","key":"10790_CR33","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/pon.5753","volume":"30","author":"FE Van Beek","year":"2021","unstructured":"Van Beek FE, Wijnhoven LMA, Holtmaat K, Custers JAE, Prins JB et al (2021) Psychological problems among cancer patients in relation to healthcare and societal costs: a systematic review. Psychooncology 30(11):1801\u20131835. https:\/\/doi.org\/10.1002\/pon.5753","journal-title":"Psychooncology"},{"issue":"14","key":"10790_CR34","first-page":"1","volume":"3","author":"M Corbett","year":"2015","unstructured":"Corbett M, Heirs M, Rose M, Smith A, Stirk L, Richardson G, Stark D, Swinson D, Craig D, Eastwood A (2015Apr 24) The delivery of chemotherapy at home: an evidence synthesis. Health and Social Care Delivery Research. 3(14):1\u201382","journal-title":"Health and Social Care Delivery Research."},{"issue":"1","key":"10790_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/iwj.13018","volume":"16","author":"S Ayaz-Alkaya","year":"2019","unstructured":"Ayaz-Alkaya S (2019) Overview of psychosocial problems in individuals with stoma: a review of literature. Int Wound J 16(1):243\u2013249. https:\/\/doi.org\/10.1111\/iwj.13018","journal-title":"Int Wound J"},{"issue":"7","key":"10790_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13070753","volume":"13","author":"LA Rat","year":"2025","unstructured":"Rat LA, Ghitea TC, Maghiar AM (2025) Psychological distress and quality of life in patients with colon cancer: predictors, moderating effects, and longitudinal impact. Healthcare Basel 13(7):753. https:\/\/doi.org\/10.3390\/healthcare13070753","journal-title":"Healthcare Basel"},{"issue":"11","key":"10790_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013779","volume":"11","author":"A Pollock","year":"2020","unstructured":"Pollock A, Campbell P, Cheyne J, Cowie J, Davis B et al (2020) Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review. Cochrane Database Syst Rev 11(11):CD013779. https:\/\/doi.org\/10.1002\/14651858.CD013779","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10790-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10790-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10790-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:27:27Z","timestamp":1781058447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10790-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10790"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10790-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Mu\u011fla S\u0131tk\u0131 Ko\u00e7man University Clinical Research Ethics Committee (Approval No. 200096\/084, date: April 16, 2020). All procedures were conducted following the ethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients in the study were provided with a detailed informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"569"}}